| Biogen Switzerland AG - Spinraza 12mg/5ml, Lösung zur intrathekalen Injektion | | 66495 | | 01 | | Spinraza 12mg/5ml | | Lösung zur intrathekalen Injektion | | M09AX07 | | Nusinersen | | 20.09.2017 | | |
| | Composition | | Solvens: nusinersenum 12 mg ut nusinersenum natricum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, kalii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml. | | Packungsbestandteile | | Solvens | | | | | | | | | | | Active Agent | Dose |
|---|
| | 12mg / 5ml |
| | BAG: Active Agent | Dose |
|---|
| | 12 mg |
| | | | Inactive agents |
|---|
| | | Calcium Chloride | | Disodium Phosphate | | Potassium Chloride | | Magnesium Chloride Hexahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate | | Sodium Hydroxide |
| |
| |
|
